
Loading, please wait...

Loading, please wait...

Faithful genome transmission during cell division is essential for preventing cancer and maintaining cellular health. A recent study identifies a site-specific phosphorylation code that regulates genome stability maintenance by stabilizing the SLX4-MUS81 interface. This mechanism ensures the timely assembly of the SMX tri-nuclease complex during early mitosis.
The SMX complex, which includes the SLX1, MUS81-EME1, and XPF-ERCC1 endonucleases, removes branched DNA intermediates. Specifically, the mitotic kinase CDK1-cyclin B orchestrates this process by phosphorylating the SLX4 scaffold. These modifications allow the complex to transition from a weak interaction to a high-affinity assembly precisely when the cell enters mitosis.
Researchers found that phosphorylation at SLX4 T1571 is necessary for the partial folding of the SAP domain. This step pre-organizes the MUS81 binding surface, effectively reducing the energy penalty for binding. Furthermore, co-phosphorylation at T1561 provides enthalpic stabilization by promoting the formation of an intermolecular beta-sheet with MUS81. Together, these two sites convert the marginally stable interface into a robust, high-affinity structure.
In human cells, this dual-site phosphorylation is critical for protecting the genome. Specifically, it stimulates MUS81-EME1 nuclease activity and prevents DNA damage. Consequently, variants at these phosphorylation sites could lead to genome instability disorders and may represent potential targets for precision oncology therapies.
SLX4 acts as a molecular scaffold that coordinates the assembly of various endonucleases, such as MUS81, into the SMX tri-nuclease complex. This complex resolves DNA intermediates during mitosis to ensure accurate chromosome segregation.
CDK1-cyclin B phosphorylates SLX4 at specific residues, T1571 and T1561. This induced phosphorylation triggers the folding of the SAP domain and strengthens the binding interface with MUS81, increasing the affinity of the complex.
Disclaimer: This content is for informational and educational purposes only. It is not intended as medical advice or to replace professional medical judgment. Refer to the latest local and national guidelines for clinical practice.
References
Payliss BJ et al. Dual-site phosphorylation of SLX4 stabilizes the SLX4-MUS81 interface to promote mitotic SMX assembly and genome protection. Nucleic Acids Res. 2026 Mar 17. doi: undefined. PMID: 41841343.
Wyatt HDM, West SC. Regulation of the SMX Tri-nuclease Complex during the Cell Cycle. Trends Biochem Sci. 2023 Feb;48(2):123-136.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers identify a site-specific phosphorylation code on SLX4 that stabilizes its interaction with MUS81, essential for genome protection during mitosis...
7 months ago

Explore why official drug package inserts fail to reflect modern evidence for clozapine prescribing. Learn how legal standards of care, case law, slow titration, and vital adverse event monitoring empower clinicians to prioritize evidence-based medical practice over outdated manufacturer labeling.
Today

Occult maternal malignancy accounts for 3.82% of persistent unreportable NIPT results with genomic noise. Multiple chromosomal aberrations, notably on chromosome 18, warrant thorough oncological evaluation and whole-body MRI to ensure timely maternal diagnosis while preserving fetal care.
Today

This article reviews the forensic and clinical complexities of acute myocarditis arising on left ventricular hypertrophy in children, highlighting early diagnostic red flags and multidisciplinary postmortem autopsy protocols.
Today

A randomized controlled trial demonstrates that an eight-week dual-task training intervention significantly improves static and dynamic postural control over standard balance exercises in individuals with chronic ankle instability, addressing critical neurocognitive deficits during athletic and daily activities.
Today

A retrospective cohort study of 7,716 ICU patients from the MIMIC-IV database demonstrates that Gradient Boosting Decision Trees significantly outperform traditional SOFA scores in predicting in-hospital mortality among patients with sepsis and diabetes, with SHAP analysis providing clinical interpretability.
Today